Research
Pioneering Scientific Research
Research
Behavioral Research
Biostatistics
Cell & Gene Therapy
Cell Biology
Data Science
Diagnostics & Biomarkers
Disease Prevention
Epidemiology
Gene Regulation & Expression
Genetics & Genomics
Global Health
Health Economics
Hematopoietic Transplantation
Immunotherapy
Infectious Diseases
Microbiome
Survivorship
Vaccine Development
Virology
Diseases
Autoimmune Diseases
Cancers
Coronavirus (COVID-19)
Genetic Disorders
HIV/AIDS
Divisions
Basic Sciences Division
Clinical Research Division
Human Biology Division
Public Health Sciences Division
Vaccine and Infectious Disease Division
Clinical Trials & Studies
Clinical Trials FAQ
Patient Treatment & Support
Meet Our Clinicians
Make an Appointment
Patient Stories
Long-Term Follow-Up
Survivorship Program
Faculty & Lab Directory
COVID-19 Clinical Research Center
Education & Training
Institutes, Networks & IRCs
Projects & Studies
Scientific Publications
Shared Resources
Investors & Industry
Collaborating for Cures
Business Development
Available Technologies
Collaborations & Startups
Commercialization
Events & Conferences
Team
News
Driving Innovation
Shared Facilities
GMP Manufacturing
Team Science
Data-Intensive Bioscience
Contact Us
About Us
Cures Start Here
About The Hutch
Accountability & Impact
Diversity, Equity & Inclusion
Facilities & Infrastructure
History
Honors & Awards
Institutional Partners & Collaborations
Leadership
Mission & Values
Contact Us
Campus Map
Virtual Campus Visit
New
Scientific Staff Directory
Global Locations
Careers
Internships
Educational Outreach
Events and Seminars
For the Media
Ways to Give
Why Your Gift Matters
Give Now
Honor a Loved One
Give Through Your Will
Give Through Your Donor Advised Fund
Give Through Your Foundation
Make a Corporate Gift
Create an Endowment
Join a Gift Club
Fundraise for Fred Hutch
Log In to Your Fundraiser
Attend a Virtual Event
Support Our Science
Greatest Need and Impact
Cancer Research
COVID-19 Research
Immunotherapy, Data Science, and the Steam Plant
Diversity, Equity and Reduction of Health Disparities
Fearless Science Needs Us
Other Ways to Give
Give Monthly
Donate Stock
Give at Work
Donate Your Vehicle
Contact Philanthropy
Careers
News
Contact
Submit
Donate
Now
Research
Pioneering Scientific Research
Research
Research
Behavioral Research
Biostatistics
Cell & Gene Therapy
Cell Biology
Data Science
Diagnostics & Biomarkers
Disease Prevention
Epidemiology
Gene Regulation & Expression
Genetics & Genomics
Global Health
Health Economics
Hematopoietic Transplantation
Immunotherapy
Infectious Diseases
Microbiome
Survivorship
Vaccine Development
Virology
Diseases
Diseases
Autoimmune Diseases
Cancers
Coronavirus (COVID-19)
Genetic Disorders
HIV/AIDS
Divisions
Divisions
Basic Sciences Division
Clinical Research Division
Human Biology Division
Public Health Sciences Division
Vaccine and Infectious Disease Division
Clinical Trials & Studies
Clinical Trials & Studies
Clinical Trials FAQ
Patient Treatment & Support
Patient Treatment & Support
Meet Our Clinicians
Make an Appointment
Patient Stories
Long-Term Follow-Up
Survivorship Program
Faculty & Lab Directory
COVID-19 Clinical Research Center
Education & Training
Institutes, Networks & IRCs
Projects & Studies
Scientific Publications
Shared Resources
Investors & Industry
Collaborating for Cures
Business Development
Business Development
Available Technologies
Collaborations & Startups
Commercialization
Events & Conferences
Team
News
Driving Innovation
Driving Innovation
Shared Facilities
GMP Manufacturing
Team Science
Data-Intensive Bioscience
Contact Us
About Us
Cures Start Here
About The Hutch
About The Hutch
Accountability & Impact
Diversity, Equity & Inclusion
Facilities & Infrastructure
History
Honors & Awards
Institutional Partners & Collaborations
Leadership
Mission & Values
Contact Us
Contact Us
Campus Map
Virtual Campus Visit
New
Scientific Staff Directory
Global Locations
Careers
Internships
Educational Outreach
Events and Seminars
For the Media
Ways to Give
Why Your Gift Matters
Give Now
Honor a Loved One
Give Through Your Will
Give Through Your Donor Advised Fund
Give Through Your Foundation
Make a Corporate Gift
Create an Endowment
Join a Gift Club
Fundraise for Fred Hutch
Fundraise for Fred Hutch
Log In to Your Fundraiser
Attend a Virtual Event
Support Our Science
Support Our Science
Greatest Need and Impact
Cancer Research
COVID-19 Research
Immunotherapy, Data Science, and the Steam Plant
Diversity, Equity and Reduction of Health Disparities
Fearless Science Needs Us
Other Ways to Give
Other Ways to Give
Give Monthly
Donate Stock
Give at Work
Donate Your Vehicle
Contact Philanthropy
Careers
News
Contact
Donate Now
Hutch News
Science Spotlight
News Releases
Scientific Publications
For the Media
Media Coverage
Stories tagged Paul Nghiem
Results per Page:
20
5
10
20
50
100
New Scientific Publications
Each week, Fred Hutch librarians search PubMed and Web of Science to discover new papers published by Fred Hutch authors
4 NEW
Week of April 11, 2021
$12M NIH grant to study rare, aggressive skin cancer
Fred Hutch, UW researchers hope to improve immunotherapies for people with Merkel cell carcinoma
Hutch News - April 16, 2019
Tags
merkel cell carcinoma
immunotherapy
Paul Nghiem
Denise Galloway
Philip D Greenberg
Shailender Bhatia
Aude Chapuis
David Koelle
TCR
Transplant and Immunotherapy
Clinical Research
Human Biology
Share
Pembrolizumab treatment for Merkel cell carcinoma
From the Nghiem Laboratory, Clinical Research Division
Science Spotlight - March 18, 2019
Tags
Paul Nghiem
Clinical Research
Share
On immunotherapy trial, long-term survivors of deadly skin cancer point to a hopeful future
Once unheard-of survival rates seen among patients with advanced Merkel cell carcinoma
Hutch News - February 06, 2019
Tags
immunotherapy
Transplant and Immunotherapy
merkel cell carcinoma
pembrolizumab
Clinical Research
cancer immunotherapy trials network
Martin Cheever
Paul Nghiem
Share
Seattle team pivotal to FDA OK on drug for rare skin cancer
UW Medicine and Fred Hutch had key roles in clinical trial of immunotherapy option for often-lethal Merkel cell cancer
News Releases - December 20, 2018
Tags
merkel cell carcinoma
cancer immunotherapy trials network
Martin Cheever
Paul Nghiem
Share
Revealing a new way that cancer can evade immunotherapy — and, maybe, how to stop it
How a new technology solved a mystery and honors one man’s legacy
Hutch News - September 24, 2018
Tags
immunotherapy
Transplant and Immunotherapy
merkel cell carcinoma
Aude Chapuis
Kelly Paulson
Paul Nghiem
t cell therapy
checkpoint inhibitors
gene expression
hla gene
Clinical Research Division (CRD)
clinical trials
pathogen-associated malignancies
Share
Fred Hutch at ASCO
Immunotherapy advances, insights into health economics and leadership awards dominate oncology gathering
Hutch News - June 05, 2018
Tags
Nancy Davidson
Julie Gralow
Paul Nghiem
Gary Lyman
hicor
immunotherapy
clinical trials
ASCO 2018
merkel cell carcinoma
cancer research
Veena Shankaran
Seth Pollack
Cameron Turtle
Joshua Roth
Scott Ramsey
Lotte Steuten
Joseph Unger
Manoj Menon
biosimilars
biologics
CAR t-cell
Clinical Research
Good News
Share
Immunotherapy has long-term benefit for patients with advanced Merkel cell carcinoma
‘Incredibly big change’ in treatment of deadly skin cancer, new data show
Hutch News - June 04, 2018
Tags
Paul Nghiem
Clinical Research
immunotherapy
Transplant and Immunotherapy
checkpoint inhibitors
pembrolizumab
merkel cell carcinoma
skin cancer
ASCO 2018
pathogen-associated malignancies
Share
10 highlights of Fred Hutch science in 2017
A look back at notable discoveries in cancer immunotherapy, HIV prevention and more
Hutch News - December 28, 2017
Tags
Cameron Turtle
Clinical Research
CAR t-cell
Transplant and Immunotherapy
Soheil Meshinchi
mylotarg
Tumor specific translational research
Paul Nghiem
merkel cell carcinoma
immunology
Jason Bielas
RNA
Lawrence Corey
hiv
hiv vaccine
hiv vaccine trials network
Vaccine and Infectious Disease
Human Biology
Vaccine development - Viral cancers
aspirin
Colorectal Cancer
Cancer etiology - prevention - outcomes
Polly A Newcomb
Public Health Sciences
Steven Henikoff
genome
Ruth Etzioni
metastasis
Breast Cancer
Matthias Stephan
bioengineering
Bezos
Obliteride
philanthropy
Molecular basis of cancer
Share
Galloway receives NCI Outstanding Investigator Award
Leader in HPV research will work to improve detection, prevention and treatment of virally caused cancers
Hutch News - September 21, 2017
Tags
Denise Galloway
Paul Nghiem
cervical carcinoma
Human Biology
Public Health Sciences
hpv
HPV vaccine
merkel cell carcinoma
pathogen-associated malignancies
Pathogen-Associated Malignancies IRC
Share
She was given a few months to live. Then, ‘a true miracle.’
Hutch News - July 11, 2017
Tags
Clinical Research
Transplant and Immunotherapy
checkpoint inhibitors
immunotherapy
merkel cell carcinoma
Paul Nghiem
clinical trials
patient stories
Share
A Merkel cell carcinoma patient failed to qualify for one clinical trial, but a later experimental treatment sent her into complete remission
Hutch News - June 09, 2017
Tags
Shailender Bhatia
immunotherapy
merkel cell carcinoma
Paul Nghiem
Clinical Research
Aude Chapuis
Share
Triple therapy for rare skin cancer shows promise in small, early-stage trial
Combo of T-cell therapy, newly FDA-approved drug and another immune booster kept cancer at bay for three of four patients with metastatic Merkel cell carcinoma
Hutch News - May 31, 2017
Tags
Aude Chapuis
Paul Nghiem
merkel cell carcinoma
immunotherapy
t cell therapy
checkpoint inhibitors
Clinical Research
metastasis
ASCO 2017
Transplant and Immunotherapy
Pathogen-Associated Malignancies IRC
Share
With immunotherapy trial, ‘a real paradigm shift’ in rare skin cancer
Investigators report ‘extraordinarily’ long-lasting treatment responses in patients with chemo-resistant, metastatic Merkel cell carcinoma
Hutch News - April 03, 2017
Tags
merkel cell carcinoma
Paul Nghiem
Immunology
immunotherapy
AACR 2017
Transplant and Immunotherapy
ASCO 2018
Share
Immunotherapy drug becomes first therapy approved by FDA for rare skin cancer
Benefit seen in nearly one-third of patients ‘with no hope at all of surviving’ their treatment-resistant Merkel cell carcinoma
Hutch News - March 24, 2017
Tags
Paul Nghiem
Clinical Research
merkel cell carcinoma
skin cancer
immunotherapy
Transplant and Immunotherapy
Share
Immunotherapy trial in rare skin cancer named one of 2016’s major advances in clinical cancer research and care
Study found long-lasting responses to immunotherapy drug in patients with Merkel cell carcinoma
Hutch News - February 02, 2017
Tags
Paul Nghiem
Martin Cheever
cancer immunotherapy trials network
merkel cell carcinoma
Skin Cancer
Transplant and Immunotherapy
checkpoint inhibitors
Good News
Share
New project: CAR T cells for HIV cure?
Dr. Larry Corey wins $2.6M grant to investigate immunotherapy's potential to bring about long-term HIV remission
Hutch News - January 19, 2017
Tags
Lawrence Corey
hiv cure
Vaccine and Infectious Disease
Vaccine development - Viral cancers
merkel cell carcinoma
Paul Nghiem
Clinical Research
Joshua Hill
Infectious Disease
Matthew Trunnell
big data
Keith Jerome
Michael Boeckh
Steven Pergam
human microbiome
Good News
Share
Key stories of Fred Hutch research from 2016
A roundup of some of our favorite 2016 stories on research at Fred Hutch
Hutch News - December 30, 2016
Tags
immunotherapy
merkel cell carcinoma
HVTN
Chronic Myeloid Leukemia
Prostate Cancer
fertility after cancer
precision medicine
Jennifer Adair
David G Maloney
Paul Nghiem
Glenda Gray
Jerald P Radich
Obliteride
Peter Nelson
Gary Lyman
Eric Chow
Vaccine and Infectious Disease Division (VIDD)
Clinical Research
Share
‘A place where miracles happen’: Opening of Bezos Family Immunotherapy Clinic highlights patient-focused science
Research symposium and ribbon cutting celebrates first-of-its-kind facility for experimental immunotherapies
Hutch News - December 16, 2016
Tags
immunotherapy
Bezos
Bezos Family Immunotherapy Clinic
Stanley R Riddell
Frederick R Appelbaum
Cameron Turtle
Rainer Storb
Philip D Greenberg
Paul Nghiem
T cell
SCCA
Seattle Cancer Care Alliance (SCCA)
D. Gary Gilliland
Lymphoma
Transplant and Immunotherapy
Share
A new blood test detects recurrence of rare skin cancer
$200 assay can accurately signal return of Merkel cell carcinoma — in some cases catching tumors earlier than expensive imaging
Hutch News - December 12, 2016
Tags
merkel cell carcinoma
Clinical Research
Human Biology
Paul Nghiem
Denise Galloway
virus
immunotherapy
pembrolizumab
cancer recurrence
Molecular basis of cancer
Share
'Finally showing hope': Immunotherapy trial results transforming care for rare skin cancer
Immunotherapy trial results transforming care for rare skin cancer
Hutch News - April 19, 2016
Tags
Clinical Research
Paul Nghiem
Martin Cheever
Shailender Bhatia
merkel cell carcinoma
immunotherapy
immune stimulators
clinical trials
cancer immunotherapy trials network
ASCO 2018
Share
Fred Hutchinson Cancer Research Center
Hutch News
Last Modified, April 02, 2020